Expression of SDF-1α and leptin, and their effect on expression of angiogenic factors in mouse ovaries by Park, Min Jung et al.
www.eCERM.org Copyright © 2011. THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE 135
ORIGINAL ARTICLE
http://dx.doi.org/10.5653/cerm.2011.38.3.135
pISSN 2233-8233 · eISSN 2233-8241
Clin Exp Reprod Med 2011;38(3):135-141
Expression of SDF-1α and leptin, and their effect on 
expression of angiogenic factors in mouse ovaries
Min Jung Park
1, Sea Hee Park
1, Su Kyung Lee
1, Sung Eun Moon
2, Hwa Sook Moon
2, Bo Sun Joo
1
1Center for Reproductive Medicine, 
2Department of Obstetrics and Gynecology, Good Moonhwa Hospital, Busan, Korea 
Objective: Ovarian angiogenesis plays an important role in folliculogenesis. However, little is known about the expression of angiogenic fac-
tors during follicular development according to female age. Stromal cell derived factor-1α (SDF-1α) plays a role in granulosa cell survival and 
embryo quality as an angiogenic chemokine. Leptin is also involved in folliculogenesis and angiogenesis. This study examined expression of 
SDF-1α and leptin, and their effects on the expression of angiogenic factors in the ovary during follicular development according to female age. 
Methods: Ovaries were collected from C57BL mice of two age groups (6-9 weeks and 24-26 weeks) at 6, 12, 24, and 48 hours after 5 IU preg-
nant mare’s serum gonadotropin (PMSG) injection. The expression of ovarian SDF-1α and leptin mRNA was evaluated by RT-PCR. In the organ 
culture experiment, the ovaries were cultured in transwell permeable supports with Waymouth’s medium treated with various doses of SDF-1α 
(50-200 ng/mL) or leptin (0.01-1 μg/mL) for 7 days. Then, mRNA expression of vascular endothelial growth factor (VEGF), endothelial nitric ox-
ide synthase (eNOS), and visfatin were examined in the cultured ovaries.  
Results: Expression of SDF-1α and leptin in the ovary was significantly lower in the aged mouse group compared to the young mouse group 
(p<0.05). Expression of these two factors increased with follicular development after PMSG administration. SDF-1α treatment stimulated visfa-
tin expression in a dose-dependent manner, while leptin treatment significantly increased eNOS expression. 
Conclusion: These results suggest that decrease of ovarian SDF-1α and leptin expression may be associated with aging-related reduction of ovar-
ian function. SDF-1α and leptin may play a role in follicular development by regulating the expression of angiogenic factors in mouse ovaries.
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Introduction
It is well known that ovarian angiogenesis plays an important role 
in a series of events of folliculogenesis such as follicular growth and 
the selection of dominant follicle by delivering hormones, hormone 
precursors, oxygen and nutrients [1,2]. For this reason, the selected 
follicles possess a more elaborate microvasculature than other folli-
cles and mature follicles have the highest vascular density [3,4]. These 
facts indicate that an active blood supply to the ovary seems to be 
essential for the induction of oocytes with good quality [5].
Advancing female age is an important factor contributing to an in-
creasing incidence of infertility, but remains a fastidious problem in 
infertility treatment. With the advance of a female’s age, chromosom-
al abnormality and production of abnormal oocytes increase and for 
the same reason the number of ovulated oocyte decreases and oo-
cyte quality worsens [6-8]. A recent review suggested a possible 
mechanism for age-related nuclear and cytoplasmic damage that it 
may occur as a result of inadequate ovarian angiogenesis in primor-
dial follicles as well as in ovarian stroma vessels [9]. However, little is 
known about the expression of angiogenic factors according to fe-
male age during folliculogenesis. 
Stromal cell derived factor-1α (SDF-1α), one of important chemotac-
tic chemokines [10], induces endothelial progenitor cells from bone 
marrow and is involved in angiogenesis by regulating the expression 
of vascular endothelial growth factor (VEGF) [11,12]. In addition, it 
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has been reported that SDF-1α recruits immune cells into preovula-
tory follicles and is involved in ovarian function by improving the sur-
vival of granulosa cells and oocyte quality [13,14]. 
Leptin, a 16 kDa small protein, initially known as adipokine secreted 
by adipose tissues, is involved in weight control, but recently, it has 
been reported that leptin involves in hematopoiesis and vascular for-
mation by promoting the expression of VEGF and angiogenesis with 
VEGF and fibroblast growth factor (FGF) [15-18].
Furthermore, evidences have accumulated that leptin is involved in 
folliculogenesis by suppressing the apoptosis of granulosa cells in 
the immature rat, by promoting the maturation to fertile stages and 
by improving nuclear and cytoplasmic maturations of oocytes [19-
22]. These results imply that leptin has promoting effects on both cell 
division and angiogenesis and it can be postulated that it effectively 
activates ovarian neovascularization. 
Therefore, this study was carried out to examine the ovarian expres-
sion of SDF-1α and leptin during follicular development according to 
female age and also to investigate the effects of these factors on the 
expressions of angiogenic factors by ovarian tissue cultures in vitro. 
Methods
This study was approved by the Institutional Review Board of Pusan 
National University Hospital, Korea.
1. Animals
In all experiments, C57BL inbred mice were purchased from the Ko-
rea Experimental Animal Center (Daegu, Korea). The mice were main-
tained on a light-dark cycle, with the light on at 5:00 AM and off at 
7:00 PM, and with food and water available ad libitum.
2. Assessment of ovarian SDF-1α and leptin after 
superovulation induction
Pregnant mare’s serum gonadotropin (PMSG) (Sigma, St Louis, MO, 
USA) of 5 IU was injected intraperitoneally into female mice of two 
age groups (6-9 weeks old and 24-26 weeks old) in order to synchro-
nize the estrus cycles. Ovarian tissues were collected 6, 12, 24, and 48 
hours post PMSG injection and the expressions of SDF-1α and leptin 
mRNA were assessed by the reverse transcriptase-polymerase chain 
reaction (RT-PCR) method. 
3. Ovarian tissue culture and treatment of SDF-1α and leptin 
To induce ovulation and synchronize the estrus cycles, 5 IU of PMSG 
was injected and 48 hours later followed by the injection of 5 IU of 
human chorionic gonadotropin (hCG, Sigma) in the 9-11 week-old 
female mice. Two days after hCG injection, the ovarian tissues were 
collected, and the adipose tissue and connective tissues surrounding 
the ovary were removed using a 26-G needle. The isolated ovarian 
tissues were washed three times with normal saline and two times 
with culture medium. Then the ovarian tissues were cultured in Way-
mouth’s medium (Invitrogen, Carlsbad, CA, USA) on Transwell per-
meable supports (0.4 μm Millicell-CM; Millipore, Bedford, MA, USA) 
for 7 days in 37˚C, 5% CO2 incubator (Figure 1). 
Waymouth’s medium was supplemented with 10% FBS, 0.23 mM 
pyruvic acid, 3 mg/mL BSA, 1x ITS supplement (Invitrogen) and peni-
cillin/streptomycin. Various concentrations of SDF-1α (50, 100 and 
200 ng/mL, Cell Science, Inc., Canton, MA, USA) and leptin (0.01, 0.1 
and 1 μg/mL, BioSource International, Inc., Camarillo, CA, USA) were 
added in the culture medium throughout the whole incubation peri-
od. These two factors were not added for the controls. The culture 
medium was replaced with fresh medium in every 2 days. Expres-
sions of mRNAs of angiogenic factors such as VEGF, endothelial nitric 
ox ide synthase (eNOS), and visfatin were assessed by RT-PCR method.
4. RNA preparation and RT-PCR
Total RNA was extracted using Trizol reagent (Invitrogen) according 
to the manufacturer’s protocol. Complementary DNA (cDNA) was 
synthesized from 5 μg of total RNA with AMV Reverse Transcriptase 
(Promega, Madison, WI, USA) using a random hexamer (Bioneer, 
Daejon, Korea) at 42˚C for 1 hour. Each cDNA was subjected to poly-
merase chain reaction (PCR) amplification using gene-specific prim-
ers (Table 1). GAPDH expression was used as control. PCR products 
Figure 1. Organ culture system of ovaries. 1, ovaries; 2, transwell per-
meable support (Millipore filter); 3, medium; 4, plain medium; 5, 
4-well dish. 
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were visualized by electrophoresis on 1.2% agarose gel. The PCR 
bands were quantified and normalized relative to the control band 
with Image J (National Institutes of Health Image Software, ver. 1.35d,  
NIH, Bethesda, MD, USA). Two samples were prepared for each tissue 
and double experiments were performed. The experiments were re-
peated 3 times. 
5. Statistics 
Data analysis was performed using SPSS ver.12.0 (SPSS Inc., San Ra-
fael, CA, USA), with a value of p<0.05 being considered significant. 
Differences between groups were tested using Mann-Whitney U-
tests. All data were expressed as mean±SE. 
Results 
1. Expressions of ovarian SDF-1α and leptin genes according to 
female age
Ovarian expression of SDF-1α mRNA was significantly low in the 
old mice when compared to the young (p<0.05). Regardless of age, 
ovarian expression of SDF-1α mRNA post PMSG injection increased 
as the follicles developed, and the increase tendency was significant-
ly lower in the old mice than the young (p<0.01) (Figure 2). 
Ovarian leptin mRNA also expressed significantly low in the old mice 
when compared to the young (p<0.005). As follicles grew after PMSG 
injection, leptin mRNA expression in the ovary was increased regard-
less of age, and the tendency of the increase was significantly low in 
the old mice than the young (p<0.05) (Figure 3). 
Figure 2. Reverse transcriptase-polymerase chain reaction (RT-PCR) 
detection for stromal cell derived factor-1 α (SDF-1α) expression in 
ovaries of young (6-9 weeks old) and aged (24-26 weeks old) female 
mice. Whole ovaries were collected 0, 6, 12, 24, and 48 hours after pre-
gnant mare’s serum gonadotropin (PMSG) injection (n=4/point in 
time). The graphical representation of SDF-1α intensity normalized to 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown below 
a representative example of RT-PCR (n=3). 
ap<0.05 and 
bp<0.01.
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Figure 3. Reverse transcriptase-polymerase chain reaction (RT-PCR) 
detection for leptin expression in ovaries of young (6-9 weeks old) 
and aged (24-26 weeks old) female mice. Whole ovaries were collect-
ed 0, 6, 12, 24, and 48 hours after pregnant mare’s serum gonadotro-
pin (PMSG) injection (n=4/point in time). The graphical representa-
tion of leptin intensity normalized to glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) are shown below a representative example 
of RT-PCR (n=4). 
ap<0.05, 
bp< 0.01, and 
cp<0.005. 
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Table 1. Primers sequences used for polymerase chain reaction amplification and conditions
Gene Primers (forward/reverse) Tm (°C) Cycles Size (bp)
SDF-1α CGCCAGAGCCAACGTCAAG/TTTA AAGCTTTCTCCAGGTAC 58 35 152
Visfatin CTTGTTCAGTCCTGGTATCC/GCGAAGAGACTCCTCTGTAA 58 28 148
eNOS TTCCGGCTGCCACCTGATCCTAA/AACATATGTCCTTGCTCAAGGCA 58 35 341
VEGF CTTGTTCAGAGCGGAGAAAGC/ACATCTGCAAGTACGTTCGTT 57 28 125
GAPDH ACCACAGTCCATGCCATCAC/TCCACCAC CTGTTGCTGTA 60 25 452
SDF-1α, stromal cell derived factor-1α; eNOS, endothelial nitric oxide synthase; VEGF, vascular endothelial growth factor; GAPDH, glyceraldehyde 3-phosphate 
dehydrogenase.  http://dx.doi.org/10.5653/cerm.2011.38.3.135
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2. Effects of SDF-1α and leptin on expressions of ovarian 
angiogenic factors 
To determine the effects of SDF-1α and leptin on the expressions of 
ovarian angiogenic factors, various concentrations of SDF-1α and 
leptin were treated in ovarian tissue culture, and the expressions of 
VEGF, eNOS, and visfatin mRNA were measured. SDF-1α significantly 
enhanced the expressions of visfatin and SDF-1α mRNAs in a dose-
dependent manner (p<0.01), however, it had no effect on the ex-
pressions of eNOS or VEGF mRNA (Figure 4). Regardless of the con-
centration, leptin enhanced the mRNA of leptin itself and eNOS ex-
pressions, and in particular, eNOS mRNA expression was significantly 
increased (p<0.005) (Figure 5). 
Discussion
The present study was carried out to investigate SDF-1α and leptin 
gene expressions in the ovary using different age groups of female 
mice to understand the age-related changes of ovarian angiogenic 
factor gene expressions. This study shows for the first time that ovari-
an SDF-1α and leptin mRNA expressions decreased with increasing 
age. This result suggests that these angiogenic factors might be in-
volved in the decrease in ovarian function and ovarian aging with 
advancing female age. 
The age-related decline of fertility in women is attributable to the 
decreases in number and quality of oocytes and follicles [23], and this 
reduction is primarily responsible for the apoptosis of oocytes and 
granulosa cells surrounding the oocyte [24]. SDF-1α is mainly secret-
ed by fibroblast and endothelial cells, but it has been reported that it 
is also locally secreted from ovarian granulosa cells and introduced 
into the follicular fluid [13,25]. Leptin is also synthesized mainly by 
granulosa and theca cells in the ovaries [26,27] and it inhibits the 
apoptosis of follicle cells [19]. These results indicate that apoptosis of 
granulosa cells increases with advancing female age and thereby the 
expressions of SDF-1α and leptin are decreased in the ovaries. How-
ever, the present study did not demonstrate which part these factors 
are expressed within the ovary or whether their expressions in gran-
ulosa cells decrease with age. Therefore further study on the localiza-
tion of SDF-1α and leptin expression in the ovaries by immunohisto-
chemistry is needed to warrant the result of our present study. 
Figure 4. Effect of stromal cell derived factor-1 α (SDF-1α) on visfatin, 
endothelial nitric oxide synthase (eNOS), and vascular endothelial 
growth factor (VEGF) mRNA expression in cultured mouse ovaries. 
Ovaries collected from 11-week-old-female mice were placed into 
culture and treated with SDF-1α (0, 50, 100, and 200 ng/mL) for 7 
days. SDF-1α, visfatin, eNOS, and VEGF mRNA levels were detected 
by reverse transcriptase-polymerase chain reaction (RT-PCR). The 
graphical representation of the intensity of each gene normalized to 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH, is shown be-
low a representative example of RT-PCR (n=3). 
ap<0.005 and 
bp<0.01 
(vs. 0 ng/mL). 
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Figure 5. Effect of leptin on visfatin, endothelial nitric oxide synthase 
(eNOS), and vascular endothelial growth factor (VEGF) mRNA expres-
sion in cultured mouse ovaries. Ovaries from 11 weeks old female 
mice were placed into culture and treated with leptin (0, 0.01, 0.1, and 
1 μg/mL) for 7 days. Leptin, visfatin, eNOS, and VEGF mRNA levels 
were detected by reverse transcriptase-polymerase chain reaction 
(RT-PCR). The graphical representation of the intensity of each gene 
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
are shown below a representative example of RT-PCR (n=3). 
ap<0.005 
(vs. 0 μg/mL). 
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Another limitation of this study is that the expression of SDF-1α and 
leptin was assessed at the mRNA transcript level. Considering the 
physiological role of proteins, their expressions should be evaluated 
at the protein level by western blot. For this reason, we made several 
attempts at western blotting, but failed to obtain an acceptable data 
due to very little expression of these factors. 
In this study, another notable finding is that the expressions of SDF-
1α and leptin mRNAs are enhanced as the follicle grows after the in-
duction of ovulation by PMSG administration. This result suggests 
that the expressions of SDF-1α and leptin mRNAs are induced by go-
nadotropins, and as expressed, they have potential effects on follicle 
development. The interactions between granulosa and theca cells 
are necessary to the antral follicle developments which are essential 
in oocyte maturation [28], and Skinner et al. [25] reported that SDF-
1α and VEGF expressions are controlled by granulosa and theca cells 
and that they are the representative candidate factors that are con-
cerned with the development of antral follicles. Recently, Nishigaki et 
al. [29] reported that the concentration of SDF-1α significantly de-
creased in follicles less than 14 mm in diameter when compared to 
those of 15 mm or more in diameter, and as the diameter and vol-
ume of follicle are increased, the concentrations of VEGF and SDF-1α 
in the follicular fluid are augmented and the recovery rates of oocytes 
are also increased. These results indicate that SDF-1α can play an im-
portant role in follicle growth and development. 
Ovarian folliculogenesis is inhibited in leptin-deficient mice [21], 
and the decrease of serum leptin concentration is associated with 
ovarian dysfunction [30,31]. In addition, fertility is restored by leptin 
treatment in ob/ob infertile mice [32], and the treatment of leptin 
during superovulation induction significantly increases the number 
of offspring in rabbit [33]. Moreover, in a previous report [34], we con-
firmed that the number and quality of the ovulated oocytes improved 
by the administration of leptin during superovulation induction with 
PMSG in old mice. Likewise, many studies have demonstrated the es-
sential roles of leptin in the maintenance of normal ovarian functions 
such as folliculogenesis and oocyte maturation, and our finding that 
leptin expression is increased as follicular growth reconfirms the 
above fact. 
As a result of RT-PCR analyses of 17 kinds of chemokines in 6- to 8- 
week-old normal mice, Zhou et al. [14] reported that MCP-1, RANTES, 
and IP-10 mRNAs are expressed high but SDF-1α mRNA is not ex-
pressed. This is somewhat different from our finding that SDF-1α is 
expressed in the ovaries and this discrepancy might arise from the 
differences in mouse strain or primers used in RT-PCR of SDF-1α. They 
used the CD-1 mouse strain and designed SDF-1α primers based on 
human nucleotide sequences. 
Angiogenesis actively occurs in the ovary, and the follicular micro-
vasculature develops under the control of ovarian angiogenic factors 
[35]. VEGF is one of the representative angiogenic factors and it plays 
an important role in folliculogenesis and the activities of granulosa 
cells [13,25]. It has been reported that SDF-1α promotes the expres-
sion of VEGF as well as angiogenesis with VEGF in cord vein endothe-
lial cells [36], and that neovascularization during folliculogenesis is 
dependent on the synergistic regulatory actions of SDF-1α and VEGF 
[29]. Leptin also promotes VEGF expression as well as angiogenesis 
with VEGF and FGF [15,16]. However, VEGF expression was not signif-
icantly increased by SDF-1α and leptin in the ovarian tissue culture of 
the present study (Figures 4, 5). The reason why VEGF expression is 
not induced by these two factors is unclear. Further studies on the ef-
fects of SDF-1α and leptin in ovarian VEGF expression are needed to 
determine whether VEGF expression is controlled by these two fac-
tors or mainly by in vitro culture conditions.
However, in the present ovarian tissue culture, SDF-1α and leptin 
induced the expressions of visfatin and eNOS, respectively, in a con-
centration-dependent manner. Visfatin is secreted by the adipose tis-
sue and it is an adipokine that has an insulin-like effect [37]. It has re-
cently been discovered that it is also secreted by various cells includ-
ing macrophages and amniotic epithelial cells and is concerned with 
proinflammatory responses and angiogenesis [38-40]. Recently, it 
has also been reported that there is a correlation between the con-
centration of visfatin in the follicular fluid and the number of oocytes 
retrieved in hyperstimulated women [41]. eNOS is nitric oxide syn-
thase presented in blood vessel, and nitric oxide is known as an an-
giogenesis-related factor that controls the vasodilation and the ex-
pression of VEGF [42,43]. In the end, these results indicate that SDF-
1α and leptin are involved in angiogenesis in the ovary. Therefore, it 
can be concluded that the decrease in the ovarian expressions of SDF- 
1α and leptin along with age inhibits angiogenesis and due to this 
decrease, apoptosis of granulosa and theca cells is promoted and in 
turn gives rise to a decrease in the number and quality of oocytes, 
eventually resulting in fertility decline. Further studies testing this hy-
pothesis are needed. 
Of interest, the treatment of ovarian tissue with SDF-1α and leptin 
resulted in the increased expression of SDF-1α and leptin in the ova-
ry, respectively. This result indicates that each expression of these fac-
tors might be primarily stimulated in the ovary in a paracrine or auto-
crine manner although there is a possibility that ovarian expressions 
of these factors may be regulated by negative feedback inhibition 
when their expressions are increased. 
Taken together, ovarian SDF-1α and leptin expression decrease with 
advancing female age and are promoted by gonadotropins and show 
an inclination to increase with follicular growth. These results indicate 
that ovarian SDF-1α and leptin have an important role in ovarian ag-
ing and function including folliculogenesis.   http://dx.doi.org/10.5653/cerm.2011.38.3.135
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